Patents by Inventor Lalitha VENKATARAMAN

Lalitha VENKATARAMAN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • HUMAN ALZHEIMER'S DISEASE AND TRAUMATIC BRAIN INJURY ASSOCIATED TAU VARIANTS AS BIOMARKERS AND METHODS OF USE THEREOF
    Publication number: 20230220401
    Abstract: The present invention provides detection reagents and method for determining risk of traumatic brain injury (TBI) and/or susceptibility to neurodegenerative disease in a subject.
    Type: Application
    Filed: December 20, 2022
    Publication date: July 13, 2023
    Inventors: Michael SIERKS, Lalitha VENKATARAMAN, Wei XIN
  • SYSTEM AND METHOD FOR GENERATING AUTOMATIC INSIGHTS OF ANALYTICS DATA
    Publication number: 20230087339
    Abstract: Described herein are systems and methods for generating automatic insights of analytics data. Generally, when data is uploaded or otherwise linked to or made accessible to an analytics environment, a skilled user is needed in order to generate meaningful data visualizations. The systems and methods described herein provide an automatic mechanism to generate for viewing and selection a set of meaningful data visualizations, wherein said generation is based upon a determined set of metrics, scored data columns, and scored visualizations.
    Type: Application
    Filed: September 9, 2022
    Publication date: March 23, 2023
    Inventors: PHILIPPE LIONS, RAMESH VASUDEVAN, RUTUJA JOSHI, LALITHA VENKATARAMAN, KALYAN BEEMANAPALLI, NIKHIL SURVE, LAXMINAG MAMILLAPALLI, KENNETH ENG, ALAN RICHARDSON
  • Human alzheimer's disease and traumatic brain injury associated tau variants as biomarkers and methods of use thereof
    Patent number: 11549113
    Abstract: The present invention provides detection reagents and method for determining risk of traumatic brain injury (TBI) and/or susceptibility to neurodegenerative disease in a subject.
    Type: Grant
    Filed: December 12, 2019
    Date of Patent: January 10, 2023
    Assignee: ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY
    Inventors: Michael Sierks, Lalitha Venkataraman, Wei Xin
  • ANTIBODY BASED REAGENTS THAT SPECIFICALLY RECOGNIZE NEURODEGENERATIVE DISEASE RELATED FORMS OF THE PROTEIN TDP-43
    Publication number: 20210373036
    Abstract: The invention relates to antibodies, antibody fragments and binding agents that specifically recognize TDP-43 associated with frontotemporal dementia (FTD), but not TDP-43 associated with amyotrophic lateral sclerosis (ALS) or TDP-43 associated with healthy human brain tissue, and antibodies, antibody fragments and binding agents that specifically recognize TDP-43 associated with ALS, but not TDP-43 associated FTD or TDP-43 associated with healthy human brain tissue.
    Type: Application
    Filed: April 28, 2021
    Publication date: December 2, 2021
    Inventors: Michael SIERKS, Stephanie WILLIAMS, Lalitha VENKATARAMAN
  • Antibody based reagents that specifically recognize neurodegenerative disease related forms of the protein TDP-43
    Patent number: 11022618
    Abstract: The invention relates to antibodies, antibody fragments and binding agents that specifically recognize TDP-43 associated with frontotemporal dementia (FTD), but not TDP-43 associated with amyotrophic lateral sclerosis (ALS) or TDP-43 associated with healthy human brain tissue, and antibodies, antibody fragments and binding agents that specifically recognize TDP-43 associated with ALS, but not TDP-43 associated FTD or TDP-43 associated with healthy human brain tissue.
    Type: Grant
    Filed: December 5, 2018
    Date of Patent: June 1, 2021
    Assignee: ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY
    Inventors: Michael Sierks, Stephanie Williams, Lalitha Venkataraman
  • HUMAN ALZHEIMER'S DISEASE AND TRAUMATIC BRAIN INJURY ASSOCIATED TAU VARIANTS AS BIOMARKERS AND METHODS OF USE THEREOF
    Publication number: 20210032634
    Abstract: The present invention provides detection reagents and method for determining risk of traumatic brain injury (TBI) and/or susceptibility to neurodegenerative disease in a subject.
    Type: Application
    Filed: December 12, 2019
    Publication date: February 4, 2021
    Applicant: ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY
    Inventors: Michael SIERKS, Lalitha VENKATARAMAN, Wei XIN
  • ANTIBODY BASED REAGENTS THAT SPECIFICALLY RECOGNIZE NEURODEGENERATIVE DISEASE RELATED FORMS OF THE PROTEIN TDP-43
    Publication number: 20190250171
    Abstract: The invention relates to antibodies, antibody fragments and binding agents that specifically recognize TDP-43 associated with frontotemporal dementia (FTD), but not TDP-43 associated with amyotrophic lateral sclerosis (ALS) or TDP-43 associated with healthy human brain tissue, and antibodies, antibody fragments and binding agents that specifically recognize TDP-43 associated with ALS, but not TDP-43 associated FTD or TDP-43 associated with healthy human brain tissue.
    Type: Application
    Filed: December 5, 2018
    Publication date: August 15, 2019
    Applicant: ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY
    Inventors: Michael SIERKS, Stephanie WILLIAMS, Lalitha VENKATARAMAN
  • Antibody based reagents that specifically recognize neurodegenerative disease related forms of the protein TDP-43
    Patent number: 10191068
    Abstract: The invention relates to antibodies, antibody fragments and binding agents that specifically recognize TDP-43 associated with frontotemporal dementia (FTD), but not TDP-43 associated with amyotrophic lateral sclerosis (ALS) or TDP-43 associated with healthy human brain tissue, and antibodies, antibody fragments and binding agents that specifically recognize TDP-43 associated with ALS, but not TDP-43 associated FTD or TDP-43 associated with healthy human brain tissue.
    Type: Grant
    Filed: February 2, 2015
    Date of Patent: January 29, 2019
    Assignee: ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY
    Inventors: Michael Sierks, Stephanie Williams, Lalitha Venkataraman
  • HUMAN ALZHEIMER'S DISEASE AND TRAUMATIC BRAIN INJURY ASSOCIATED TAU VARIANTS AS BIOMARKERS AND METHODS OF USE THEREOF
    Publication number: 20190010504
    Abstract: The present invention provides detection reagents and method for determining risk of traumatic brain injury (TBI) and/or susceptibility to neurodegenerative disease in a subject.
    Type: Application
    Filed: December 9, 2016
    Publication date: January 10, 2019
    Applicant: ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY
    Inventors: Michael SIERKS, Lalitha VENKATARAMAN, Wei XIN
  • ANTIBODY BASED REAGENTS THAT SPECIFICALLY RECOGNIZE NEURODEGENERATIVE DISEASE RELATED FORMS OF THE PROTEIN TDP-43
    Publication number: 20170010284
    Abstract: The invention relates to antibodies, antibody fragments and binding agents that specifically recognize TDP-43 associated with frontotemporal dementia (FTD), but not TDP-43 associated with amyotrophic lateral sclerosis (ALS) or TDP-43 associated with healthy human brain tissue, and antibodies, antibody fragments and binding agents that specifically recognize TDP-43 associated with ALS, but not TDP-43 associated FTD or TDP-43 associated with healthy human brain tissue.
    Type: Application
    Filed: February 2, 2015
    Publication date: January 12, 2017
    Applicant: ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY
    Inventors: Michael SIERKS, Stephanie WILLIAMS, Lalitha VENKATARAMAN